Characteristics of COX2 inhibitors questioned

被引：0
|
作者：
Sophie Petit-Zeman
机构：
来源：
Nature Reviews Drug Discovery | 2004年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
A health watchdog agency's decision on COX2 inhibitors highlights the difference in opinion about the use of these treatments.
引用
收藏
页码：726 / 726
相关论文
共 50 条
  • [1] Characteristics of COX2 inhibitors questioned
    Petit-Zeman, S
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (09) : 726 - 727
  • [2] Future of COX2 inhibitors
    Melnikova, I
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (06) : 453 - 454
  • [3] The development of COX2 inhibitors
    Rod J. Flower
    [J]. Nature Reviews Drug Discovery, 2003, 2 : 179 - 191
  • [4] The development of COX2 inhibitors
    Flower, RJ
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (03) : 179 - 191
  • [5] Chemoprevention with COX2 inhibitors?
    [J]. Nature Reviews Cancer, 2006, 6 (10) : 748 - 748
  • [6] Future of COX2 inhibitors
    Irena Melnikova
    [J]. Nature Reviews Drug Discovery, 2005, 4 : 453 - 454
  • [7] Have Cox2 inhibitors lived up to expectations?
    Kwong, MF
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 : 13 - 16
  • [8] Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain
    Strauss, Kenneth I.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2008, 22 (03) : 285 - 298
  • [9] COX2 inhibitors for acquired brain injuries: Is the time ripe?
    Strauss, Kenneth I.
    [J]. CRITICAL CARE MEDICINE, 2010, 38 (02) : 723 - 724
  • [10] Prevalence of COX2 expression in Middle Eastern CRC and the effect of COX2 inhibitors on cell growth in the mouse model of CRC
    Ahmed, Maqbool
    Bavi, Prashant
    Hussain, Azhar
    Al-Sanea, Nasser
    Abduljabbar, Alaa
    Ashari, Luai
    Alhomoud, Samar
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla
    [J]. CANCER RESEARCH, 2009, 69
12345